146 related articles for article (PubMed ID: 38017592)
21. [Analysis of clinicopathological characteristics, therapeutic strategy and prognosis of 501 patients with gastric neuroendocrine neoplasms attending a single center].
Zhang BL; Lu YX; Liang WQ; Gao YH; Xi HQ; Wang XX; Zhang KC; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):459-466. PubMed ID: 37217354
[No Abstract] [Full Text] [Related]
22. Comparison of Outcomes Following Thyroid Isthmusectomy, Unilateral Thyroid Lobectomy, and Total Thyroidectomy in Patients with Papillary Thyroid Microcarcinoma of the Thyroid Isthmus: A Retrospective Study at a Single Center.
Gui Z; Wang Z; Xiang J; Sun W; He L; Dong W; Huang J; Zhang D; Lv C; Qin Y; Zhang T; Shao L; Zhang P; Zhang H
Med Sci Monit; 2020 Dec; 26():e927407. PubMed ID: 33351790
[TBL] [Abstract][Full Text] [Related]
23. [Clinical features and prognoses of re-operated patients for persistent/recurrent papillary thyroid carcinoma].
Xu N; Cai YC; Sun RH; Hu BT; Liu L; Xiang YQ; Zheng WH; Chen XL; Qin G; Wang X; Shui CY; Ning YD; Zhou YQ; Li C
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Sep; 57(9):1052-1058. PubMed ID: 36177558
[No Abstract] [Full Text] [Related]
24. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
Wu MH; Shen WT; Gosnell J; Duh QY
Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
[TBL] [Abstract][Full Text] [Related]
25. Does total tumour diameter, multifocality, number of tumour foci, or laterality predict lymph node metastasis or recurrence in differentiated thyroid cancer?
Elbasan O; Ilgın C; Gogas Yavuz D
Endokrynol Pol; 2023; 74(2):153-167. PubMed ID: 37039491
[TBL] [Abstract][Full Text] [Related]
26. A Comparison of the Seventh and Eighth Editions of the AJCC Staging Systems to Predict Recurrence in Papillary Thyroid Microcarcinoma.
Chen Z; Ruan J; Yao Y; Wen L; Mao Z; Chen S; Zhu H; Zhao Y; Li Z; Fahey TJ; Teng L; Wang W
Ann Surg Oncol; 2021 Oct; 28(11):6564-6571. PubMed ID: 33521903
[TBL] [Abstract][Full Text] [Related]
27. Incidental papillary microcarcinoma of the thyroid--factors affecting lymph node metastasis.
Gülben K; Berberoğlu U; Celen O; Mersin HH
Langenbecks Arch Surg; 2008 Jan; 393(1):25-9. PubMed ID: 17690905
[TBL] [Abstract][Full Text] [Related]
28. Ultrasonography is valuable in evaluation of papillary thyroid microcarcinoma based on 5 mm tumor size.
Xia S; Dong Y; Kang H; Zhan W
J Cancer Res Ther; 2018 Jun; 14(Supplement):S319-S323. PubMed ID: 29970683
[TBL] [Abstract][Full Text] [Related]
29. Optimal value of lymph node ratio and metastatic lymph node size to predict risk of recurrence in pediatric thyroid cancer with lateral neck metastasis.
Back K; Kim TH; Lee J; Kim JS; Choe JH; Oh YL; Cho A; Kim JH
J Pediatr Surg; 2023 Mar; 58(3):568-573. PubMed ID: 35973863
[TBL] [Abstract][Full Text] [Related]
30. Medullary thyroid microcarcinoma: a population-level analysis of 310 patients.
Kazaure HS; Roman SA; Sosa JA
Cancer; 2012 Feb; 118(3):620-7. PubMed ID: 21717441
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
[TBL] [Abstract][Full Text] [Related]
32. [Correlations of serum TgAb and TPOAb and clinicopathological features of PTC in children and adolescents].
Huang DM; Zhi JT; Zhang JM; Zheng XQ; Zhao JZ; Wei SF; Gao M
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Dec; 57(12):1418-1425. PubMed ID: 36707945
[No Abstract] [Full Text] [Related]
33. Clinical features, treatment, and long-term outcome of papillary thyroid cancer in children and adolescents without radiation exposure.
Enomoto Y; Enomoto K; Uchino S; Shibuya H; Watanabe S; Noguchi S
World J Surg; 2012 Jun; 36(6):1241-6. PubMed ID: 22411092
[TBL] [Abstract][Full Text] [Related]
34. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
35. Prognostic influence of clinical and pathological factors in medullary thyroid carcinoma: a study of 53 cases.
Brandão LG; Cavalheiro BG; Junqueira CR
Clinics (Sao Paulo); 2009; 64(9):849-56. PubMed ID: 19759878
[TBL] [Abstract][Full Text] [Related]
36. Superior Located Papillary Thyroid Microcarcinoma is a Risk Factor for Lateral Lymph Node Metastasis.
Back K; Kim JS; Kim JH; Choe JH
Ann Surg Oncol; 2019 Nov; 26(12):3992-4001. PubMed ID: 31264121
[TBL] [Abstract][Full Text] [Related]
37. [Clinicopathological characteristics of papillary thyroid microcarcinoma and risk factors for central lymph node metastasis].
Wu YL; Sun JM; Zhang JJ; Cui QX; Zheng WH; Li XR
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):426-429. PubMed ID: 28635214
[No Abstract] [Full Text] [Related]
38. Which is preferred for initial treatment of papillary thyroid cancer, total thyroidectomy or lobotomy?
Wu Z; Han L; Li W; Wang W; Chen L; Yao Y; Wang Y
Cancer Med; 2021 Mar; 10(5):1614-1622. PubMed ID: 33512778
[TBL] [Abstract][Full Text] [Related]
39. [Outcomes and prognosis of radical surgery in patients with stageⅠb2 and Ⅱa2 cervical squamous cell carcinoma].
Zhou F; Chen F; Pan T; Zhu T; Zhang YL; Zhang P; Tang HR
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):361-369. PubMed ID: 35658327
[No Abstract] [Full Text] [Related]
40. Clinical Characteristics, Surgical Management, and Prognostic Factors of Medullary Thyroid Carcinoma: A Retrospective, Single-Center Study.
Wu X; Li B; Zheng C
Technol Cancer Res Treat; 2022; 21():15330338221078435. PubMed ID: 35188853
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
